{"database": "lobbying", "table": "lobbying_activities", "rows": [[3188061, "6cb41732-f98c-4ac9-948f-699318899057", "Q2", "MARSHALL & POPP, LLC", 401105121, "AMGEN USA INC.", 2024, "second_quarter", "TRD", "Issues related to waiving intellectual property protections for COVID-19 vaccines and theraputics under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement).", "SENATE", 60000, null, 0, 0, "2024-07-10T14:48:35-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3188061"], "units": {}, "query_ms": 88.13025616109371, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}